MCD vs RXST · P/E 23, rev $25.92B vs rev $139.9M
McDonald’s Corporation (MCD) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported RXST revenue for 2024-12-31 was $139.9M. Net income was -$27.5M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. RXST currently screens at market cap $198.3M.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. RXST currently screens at market cap $198.3M.
Not investment advice. Open the MCD and RXST stock pages for the full models.
Not investment advice.